Merck (MRK)
$92.82
0.33 (0.36%)
MRK Stock Quote Delayed 30 Minutes
27 Companies Increasing Dividends
Disney, PepsiCo and Seagate Technology are among companies making this week's list of dividend-increasing stocks.
Louis Navellier's Total Grade
Powered by Portfolio Grader?
Unlock Louis Navellier's
? Stock Report – FREE:
Is ? a BUY?
Powered by Portfolio Grader
A
B
C
D
F
?
Unlock Louis Navellier's
? Stock Report to Find Out – FREE:
Louis Navellier's Total Grade
Powered by Portfolio Grader?
Investing legend Louis Navellier rates ? a "?." Unlock his ? Stock Analysis to find out why – FREE:
Louis Navellier's Total Grade
Powered by Portfolio Grader?
Fundamental Grade
Quantitative Grade
- Sales Growth ?
- Operating Margin Growth ?
- Earnings Growth ?
- Earnings Momentum ?
- Earnings Surprises ?
- Analyst Earnings Revisions ?
- Cash Flow ?
- Return on Equity ?
Previous Close
$92.25
Market Cap
233.03B
PE Ratio
13.78
EPS
6.7363
Volume (Avg. Vol.)
12.30M
Day's Range
$91.78 - $93.21
52-Week Range
$81.04 - $132.70
Dividend & Yield
$3.12 (3.36%)
MRK Stock Predictions, Articles, and Merck News
Novartis Flu Vaccine Ban: Who Wins?
Two of Novartis' flu vaccines have been banned in seven countries, but the market's reaction to the move may be a bit overdone. Here's why.
Look Who’s Asking Congress for Deficit Action
It would be a little easier to abide the Campaign to Fix the Debt CEO Fiscal Leadership Council's effort -- if the execs on it weren't so hypocritical.
Top 10 Dow Dividend Stocks for October
Income investors could do a lot worse than buying into these venerable blue chips, but watch out -- one of these plays is looking pretty risky.
Should I Buy Abbott Labs? 3 Pros, 3 Cons
Success in a drug regimen meant to treat hepatitis C is buoying shares of Abbott Laboratories, but has the easy money in ABT shares already been made?
5 Ways to Invest $10,000 Now
Getting started isn't nearly as tough as you may think. And remember: Not all investments have to be in the capital markets.
6 Pharmaceutical Stocks to Buy Now
The grades of six Pharmaceutical stocks are on the rise this week on Portfolio Grader. Each of these stocks is rated an "A" ("strong buy") or "B" overall ("buy").
7 Pharmaceutical Stocks to Buy Now
The grades of seven Pharmaceutical stocks are better this week, according to the Portfolio Grader database. Every one of these stocks has an "A" ("strong buy") or "B" overall ("buy") rating.
A Healthy Portfolio Is Heavy in Health Care
Investors would be foolish to ignore the massive demographic shift and growth potential that is boosting health care stocks right now.
Should I Buy Energizer? 3 Pros, 3 Cons
Energizer just announced an aggressive cost-cutting program; will it be enough to get the stock back on track? Get the verdict on ENR.
Who Has the Best Pharma Pipeline?
A look through Big Pharma's drug pipelines shows a lot of promise across several companies, but one firm stands out as having big-time revenue growth potential.
Top 10 Dow Dividend Stocks for September
If you're worried that the markets can't hold onto their fantastic year-to-date gains, protect your money by ducking into these top Dow dividend stocks.
11 High Dividend Growth Stocks in 2012
This year has been characterized as a record year for dividend distributions paid to shareholders by cash rich companies and here are 11 solid dividend payers
5 Mutual Funds to Get Defensive With
If you're convinced the bear is eventually coming back to bite us, consider getting into one or all of these five mutual funds with defensive postures.
6 Stocks to Sell in September
The near-term trend is down, and these company names are dangerously overpriced. From Intel to Merck, see this month's list of stocks to sell.
11 American Corporations Set for Global Shopping Sprees
A legal tax dodge for U.S. companies buying offshore assets should look attractive to these 11 big multinational stocks with huge foreign stockpiles.
Gilead Poised to Go From Good to Great?
Gilead faces a pivotal FDA decision on its HIV "quad" pill Monday. Even if it's not much better than what's available, approval would be good news for investors.
The 10 Best Buffett Dividend Stocks
Despite paring back on several dividend stocks last quarter, Berkshire hasn't given up on income altogether. Here are its top dividend payers.
Eli Lilly Might Have an Alzheimer’s Cure
Eli Lilly's stock is set to soar Friday morning after a trial for its Alzheimer's drug solanezumab showed promising results for early-stage patients.
Forget ‘Earnings’ — Declining Revenue and Dividends the Real Story in Q3
The biggest concern for investors should be the individual companies they own. And right now, it’s important to look at these two factors above all else.
